Cancer · Austria
Acute myeloid leukaemia
How is it diagnosed today? Your family doctor usually arranges an urgent blood test, and may send you to a hospital specialist or straight to hospital. NHS
What do you need help with?
- Join a trialStudies open to new patients in your country, and abroad if you want.13 open trials in Austria
- Offer tissue or dataGive a sample or your health data to research.
- Get supportPatient groups, money and work, help for family.
- Access and costGetting a treatment that is not on offer here, and who pays.
- Questions for your doctorReady lists to print or copy before your next visit.
- Don't pay for thisOffers with no proof in people, and what to check first.
Where treatment stands
Four steps, from proven to unproven.
Approved in Austria
Usual treatment: Intensive chemo, sometimes a stem cell transplant. NHS
15 medicines are approved for this disease in Austria:
Show all 15
- Arsenic trioxide (Trisenox, Arsenic trioxide Accord, Arsenic trioxide medac) – approved in 2002
- Azacitidine (Onureg, Azacitidine Mylan, Azacitidine Kabi) – approved in 2008
- Cedazuridine and decitabine (Inaqovi, Inqovi) – approved in 2023
- Daunorubicin and cytarabine (Vyxeos liposomal, Vyxeos) – approved in 2018
- Decitabine (Dacogen, Decitabin Sandoz) – approved in 2012
- Gemtuzumab ozogamicin (Mylotarg) – approved in 2018
- Gilteritinib (Xospata) – approved in 2019
- Glasdegib (Daurismo) – approved in 2020
- Histamine dihydrochloride (Ceplene) – approved in 2008
- Ivosidenib (Tibsovo) – approved in 2023
- Melphalan (Phelinun) – approved in 2020
- Midostaurin (Rydapt) – approved in 2017
- Quizartinib (Vanflyta) – approved in 2023
- Venetoclax (Venclyxto, Venclexta) – approved in 2016
- Posaconazole (Noxafil, Posaconazole Accord, Posaconazole AHCL) – approved in 2005
An EU approval is valid in Austria. We did not check the national approvals in Austria, so some medicines under “Approved elsewhere” may be approved here too. We did not check whether they are sold or paid for there. Checked in the regulators' own texts on 11 Nov 2026.
Approved elsewhere (17)
- Cyclophosphamide (Frindovyx) – approved for it in the US
- Cytarabine (Cytarabine, Aracytine, Cytarabine Sandoz) – approved for it in the US and France
- Daunorubicin (Daunorubicin Hydrochloride, Daunoblastin, Cerubidine) – approved for it in the US, Switzerland, and France
- Doxorubicin (Doxorubicin Hydrochloride) – approved for it in the US
- Enasidenib (Idhifa) – approved for it in the US
- Etoposide (Celltop, Etopophos) – approved for it in France
- Filgrastim (Neupogen) – approved for it in the US
- Idarubicin (Zavedos, Idamycin PFS, Idarubicine Accord) – approved for it in the US and France
- Mercaptopurine (Purinethol) – approved for it in France
- Mitoxantrone (mitoXANTRONE) – approved for it in the US
- Olutasidenib (Rezlidhia) – approved for it in the US
- Revumenib (Revuforj) – approved for it in the US
- Sargramostim (Leukine) – approved for it in the US
- Thioguanine (Tabloid, Lanvis) – approved for it in the US and France
- Treosulfan (Grafapex) – approved for it in the US
- Tretinoin (Tretinoin, Vesanoid) – approved for it in the US, Switzerland, and France
- Ziftomenib (Komzifti) – approved for it in the US
Being tested in people
13 open trials in Austria, 635 worldwide. See the trials
- 4 chemotherapy blocks: Course 1 AIE (cytarabine/idarubicin/etoposide), Course 2 AI (cytarabine/idarubicin), Course 3 HAD (high-dose cytarabine (1g)/daunorubicin), Course 4 HA (high-dose cytarabine). (Phase 3)
- AG-120 (Phase 3)
- AG-221 (Phase 3)
- all-trans retinoic acid (ATRA) (Phase 3)
Only in the lab or in animals
Of the 20 newest articles, 2 were in animals and 1 in the lab. See them
No proof it works
Animal worm medicines (ivermectin, fenbendazole) for cancer: not approved, and not enough research in people to know if they help. American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025)
Join a trial
Studies that are taking new patients in Austria. The trial team decides who can join. Change the country at the top.
Phase 1: first tests in people · Phase 2: does it help? · Phase 3: compared with the usual treatment
0 open trials in Austria with these filters
We found no open trial in Austria with these filters.
Available abroad (32 trials)
Nearest region first. Travel and treatment abroad are often not paid for; ask your health insurer first.
Tests a structured exercise program for adults with blood cancers
NCT07912684 · ClinicalTrials.gov
Countries: Italy
- Bari, Italy – Irccs Oncologico Istituto Tumori Giovanni Paolo Ii - Bari - Uo Ematologia
- Roma, Italy – Fondazione PTV - POLICLINICO TOR VERGATA
- Verona, Italy – Aou Integrata Di Verona, Policlinico G.B. Rossi - Uoc Ematologia
Ages 18 to 75
Contact the trial teamBlood Test Study to Detect Early Blood Cancers
NCT05735704 · ClinicalTrials.gov
Countries: Czechia, Greece, Lithuania and 1 more
- Olomouc, Czechia – Fakultni nemocnice Olomouc FNOL
- Athens, Greece – National and Kapodistrian University of Athens (NKUA)
- Vilnius, Lithuania – Vilnus University Hospital Santaros Klinikos (VULSK)
Age 18 and over
Contact the trial teamFollows people with GATA2 gene mutation to study how blood changes over time
NCT05983991 · ClinicalTrials.gov
Countries: France
- Angers, France – CHU Angers
- Bordeaux, France – CHU Bordeaux
- Caen, France – CHU de CAEN
No age limit given in the registry
Contact the trial teamCollects samples from adults with myelodysplastic syndrome to study the disease
NCT04869683 · ClinicalTrials.gov
Countries: France
- Brest, France – Chu Brest
Age 18 and over
Contact the trial teamStudies memory and thinking changes in people receiving chemotherapy for blood cancers
NCT07147621 · ClinicalTrials.gov
Countries: France
- Angers, France – University hospital of Angers
Age 18 and over
Contact the trial teamLooking for epigenetic markers of acute myeloid leukemia in older adults
NCT07250217 · ClinicalTrials.gov
Countries: France
- Mulhouse, France – Groupe Hospitalier de la Région de Mulhouse et Sud Alsace
- Mulhouse, France – GHRMSA
Age 60 and over
Contact the trial teamStudy of families with blood cancer risk linked to the DDX41 gene
NCT06022016 · ClinicalTrials.gov
Countries: France
- Bordeaux, France – CHU de Bordeaux
- Limoges, France – CHU de Limoges
- Marseille, France – Institut Paoli-Calmettes
Age 18 and over
Contact the trial teamStudies bone marrow samples from children with acute leukemia
NCT05792007 · ClinicalTrials.gov
Countries: France
- Tours, France – Service de chirurgie orthopédique pédiatrique -CHRU TOURS
- Tours, France – Service d'hématologie biologique-CHRU TOURS
- Tours, France – Service d'onco-hématologie pédiatrique -CHRU Tours
Ages 1 to 15
Contact the trial teamStudies the immune environment around leukemia cells in acute myeloid leukemia
NCT06874257 · ClinicalTrials.gov
Countries: Italy
- Bologna, Italy – IRCCS Azienda Ospedaliero-Universitaria di Bologna
Age 18 and over
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamVenetoclax Added to Pre-Transplant Treatment for Blood Cancers
NCT07214064 · ClinicalTrials.gov
Ages 18 to 75
Contact the trial teamTests a lower dose of cyclophosphamide after blood stem cell transplant
NCT05436418 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
- Duarte, United States – City of Hope
Ages 12 to 120
Contact the trial teamTests whole genome sequencing alongside standard tests in leukemia and MDS
NCT04986657 · ClinicalTrials.gov
Countries: United States
- St Louis, United States – Washington University School of Medicine
Age 18 and over
Contact the trial teamCollecting blood samples to develop early cancer detection tests
NCT05334069 · ClinicalTrials.gov
Countries: United States
- Aberdeen, United States – Providence Regional Cancer System-Aberdeen
- Aitkin, United States – Riverwood Healthcare Center
- Akron, United States – Summa Health System - Akron Campus
Ages 40 to 75
Contact the trial teamTests Orca-Q donor cell therapy in children receiving blood stem cell transplants
NCT05322850 · ClinicalTrials.gov
Countries: United States
- Gainesville, United States – University of Florida
- Miami, United States – Nicklaus Children's Hospital
- Miami, United States – University of Miami
Up to age 50
Contact the trial teamOnline Survey Registry on Experiences of Cancer Patients and Caregivers
NCT02333604 · ClinicalTrials.gov
Countries: United States
- Washington D.C., United States – Cancer Support Community Research & Training Institute
Age 18 and over
Contact the trial teamCMV vaccine for stem cell donors to protect transplant patients with blood cancers
NCT06059391 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Northside Hospital
- Boston, United States – DFCI/BWH Brigham and Women's Hospital
- Duarte, United States – City of Hope Medical Center
Ages 18 to 75
Contact the trial teamTests a CMV vaccine in stem cell transplant donors and recipients
NCT07020533 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Northside Hospital
- Boston, United States – Brigham and Women's Hospital
- Duarte, United States – City of Hope Medical Center
Ages 18 to 75
Contact the trial teamEngineering T cells to better fight acute myeloid leukemia, using blood and marrow samples
NCT07743047 · ClinicalTrials.gov
Age 18 and over
Contact the trial teamStudies myelodysplastic syndromes over time to learn how the disease progresses
NCT05350748 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 0 to 120
Contact the trial teamTesting danvatirsen alone, then with venetoclax, in relapsed blood cancers
NCT05986240 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M.D. Anderson Cancer Center, Department of Leukemia
- The Bronx, United States – Montefiore Medical Center
Age 18 and over
Contact the trial teamSupportive care for older adults starting leukemia treatment
NCT07777471 · ClinicalTrials.gov
Countries: United States
- Birmingham, United States – University of Alabama at Birmingham
Age 18 and over
Contact the trial teamFollowing People and Families With RUNX1 Gene Changes Over Time
NCT03854318 · ClinicalTrials.gov
Countries: United States
- Bethesda, United States – National Institutes of Health Clinical Center
Ages 0 to 100
Contact the trial teamTests a new oral menin inhibitor with two other pills in acute myeloid leukemia
NCT05360160 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Age 12 and over
Contact the trial teamOnline Holistic Care Platforms for Children With Leukemia or Brain Tumors and Their Parents
NCT07805096 · ClinicalTrials.gov
Countries: Taiwan
- Taipei, Taiwan – National Taiwan University Children's Hospital
Age 7 and over
Contact the trial teamVenetoclax added to transplant preparation for high-risk blood cancers
NCT04708054 · ClinicalTrials.gov
Countries: United States
- Houston, United States – M D Anderson Cancer Center
Ages 18 to 70
Contact the trial teamRegistry collecting health records and patient reports from people with cancer
NCT07756034 · ClinicalTrials.gov
Countries: United States
- Chicago, United States – Tempus AI
No age limit given in the registry
Contact the trial teamDonor Stem Cell Transplant Using Treosulfan for Blood Cancers
NCT04195633 · ClinicalTrials.gov
Countries: United States
- Seattle, United States – Fred Hutch/University of Washington Cancer Consortium
Age 0 and over
Contact the trial teamDecitabine with chemotherapy and radiation before stem cell transplant for blood cancers
NCT06928662 · ClinicalTrials.gov
Countries: United States
- Seattle, United States – Fred Hutch/University of Washington Cancer Consortium
Age 18 and over
Contact the trial teamCompares two palliative care approaches for adults with acute myeloid leukemia
NCT05237258 · ClinicalTrials.gov
Countries: United States
- Atlanta, United States – Emory University
- Baltimore, United States – Johns Hopkins University
- Birmingham, United States – University of Alabama Birmingham
Ages 18 to 120
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTesting itraconazole alongside standard care for acute myeloid leukemia
NCT07069933 · ClinicalTrials.gov
Countries: Egypt
- Al Mansurah, Egypt – Clinical Oncology and Nuclear Medicine of Mansoura University Hospital, Mansoura,
Ages 18 to 100
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamBlood Markers and Clotting Tests in Newly Diagnosed Acute Myeloid Leukemia Patients
NCT06714071 · ClinicalTrials.gov
Countries: Egypt
- Asyut, Egypt – Assiut University
Ages 18 to 90
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial teamTests iNK cell therapy in adults with relapsed or refractory acute myeloid leukemia
NCT06702098 · ClinicalTrials.gov
Countries: China
- Guangzhou, China – Guangzhou Ruixin Biotechnology Co., Ltd
Ages 18 to 80
The registry has not updated this record for a long time. Ask the team whether it is still open.
Contact the trial team
How to get into an early trial
- A lab does not treat patients, so you cannot phone the lab to get a new treatment.
- Ask your doctor to look at phase 1 trials with you. These are the first tests in people.
- If one fits, your doctor sends a referral to the trial centre.
- The trial team checks whether you can join and decides.
Trial data: ClinicalTrials.gov, courtesy of the U.S. National Library of Medicine; it does not endorse this site. EU trials: EU Clinical Trials Information System (CTIS), European Medicines Agency. We show the registry records; the trial team has the last word on who can join.
Latest research
The five newest articles. The label comes from the PubMed index: whether it was tested in people, in animals or only in the lab.
- Higher Relapse Rate and Resource Utilization With Ara-C Consolidation Chemotherapy Alone Compared to Hematopoietic Cell Transplantation in First Remission in a Cohort of Younger Adults With Acute Myeloid Leukemia With t(8;21) (q22;q22.1).J Hematol · 2026-10-31
- In animalsAll-Trans Retinoic Acid-Loaded Fe-N3-Se Single-Atom Nanozymes Enable Redox-Guided Differentiation Therapy for Acute Myeloid Leukemia.ACS Nano · 2026-11-17
- In animalsIntravital Microscopy-Guided Live-Cell Isolation for Spatially Resolved Transcriptional Analysis of Leukemia-Immune Interactions.J Vis Exp · 2026-11-10
- Impact of Molecular and Cytogenetic Risk Stratification, Early Treatment Response, and Inflammatory Biomarkers on Survival in Intensively Treated Non-Acute Promyelocytic Leukemia Acute Myeloid Leukemia.World J Oncol · 2026-11-11
- In peopleEarly bone marrow-guided venetoclax management in frontline unfit acute myeloid leukemia: a two-stage real-world study.Ann Hematol · 2026-08-20
Is it true?
Saw something on social media? Fact-check it now.
Get screened
For family members and people at higher risk: free checks can find some cancers early, before there are symptoms.
There is no routine screening for this cancer. If you have symptoms or a family history, talk to your doctor.
If several people in your family had cancer, ask your GP whether genetic counselling makes sense for you.
Offer tissue or data
You can help research move faster.
Give tissue or blood to research
Before an operation or a blood test, ask if left-over tissue or blood can go to a biobank.
- Does this hospital have a biobank?
- What will the sample be used for, and for how long?
- Can I change my mind later?
Share your health data
Ask your doctor whether there is a patient registry for your illness. You choose what you share.
Take part as a healthy volunteer
Some studies need people without the illness, often family members.
Volunteer studiesGet support
Patient groups in Austria
- Österreichische Krebshilfe
Free, anonymous counselling at regional centres in every federal state, psycho-oncology and emergency financial aid.
Phone: 01 7966450
Help for every illness in Austria (4)
- 1450 – Rund-um-die-Uhr-Gesundheitsberatung
Austria's nationwide 24/7 telephone health advice line: trained staff assess symptoms and guide callers to the appropriate care.
- Telefonseelsorge Österreich – Notruf 142
Free, confidential 24/7 emotional support and crisis line for anyone in Austria, reachable on 142.
- Gesundheitsportal Österreich (gesundheit.gv.at)
Austria's official public health portal, offering quality-assured information on diseases, prevention, health services and patient rights.
- ARGE Selbsthilfe Österreich
ARGE Selbsthilfe Österreich represents the interests of self-help groups and patient organisations in Austrian social and health policy.
Available abroad: international groups (8)
- DKMS
Finds blood stem cell donors worldwide so that people with blood cancer can have a transplant.
- Acute Leukemia Advocates Network (ALAN)
Global network of 69 acute leukaemia patient organisations (hosted by the Swiss Leukemia Patient Advocates Foundation); member list helps patients find a national group.
- European Cancer Patient Coalition (ECPC)
Umbrella of European cancer patient groups, with a patient toolbox and a legal network for cancer patients.
- European Reference Networks (European Commission)
The European Commission's 24 expert networks for rare and complex diseases; your doctor can contact them.
- EURORDIS – Rare Diseases Europe
Alliance of over 1,000 rare disease patient organisations, with a list of rare disease helplines by country.
- Workgroup of European Cancer Patient Advocacy Networks
Network of pan-European cancer patient umbrella groups (including the blood cancer networks): joint advocacy, WECAN Academy training for patient advocates, patient experience data courses.
- European Patients' Forum (EPF)
Umbrella of European patient organisations and national patient coalitions.
- International Alliance of Patients' Organizations
Global alliance of patient organisations of all diseases, promoting patient-centred healthcare.
Money and work
If the illness stops you working, ask the hospital social worker which benefits you can claim.
- Which sick-pay or disability benefits can I apply for?
- Is there help for the carer in the family?
- Are travel costs to treatment paid back?
After a loss
If someone you love has died, you do not have to go through it alone. Many families ask themselves whether they missed something; the care team can talk this through with you.
We have no grief support group in Austria in our list yet. The hospital's social worker or palliative team can tell you where to find one.
Hospitals and hospices have chaplains and counsellors, for any faith or none.
Some families decide to give tissue to research after death, so that the illness can be studied. If you want to, ask the treating hospital early whether it has such a programme.
Access and cost
- If no trial fits, your doctor can ask the company and the medicines authority whether early access (compassionate use) is possible.
- In Austria the medicines agency BASG lists the early-access programmes that are running. BASG (Austria): list of compassionate use programmes, no. 054
- In the EU you may get planned care in another EU country. Ask your health insurer before you go. Your Europe: planned medical treatment abroad
- Some medicines for this disease are approved abroad but maybe not here: see “Approved elsewhere” under “Approved in Austria” above.
Don't pay for this
No one will cure you through a Facebook message or ask you to invest money.
- Animal worm medicines bought online (ivermectin, fenbendazole)
They are made for animals and not tested for cancer in people. High doses can cause seizures or coma, fenbendazole has caused liver damage, they may weaken your cancer treatment, and they can keep you out of a trial.
American Cancer Society: What to Know About Ivermectin (21 May 2026) · American Cancer Society: What to Know About Fenbendazole (21 Oct 2025) · ASCO: Oncologists urged to discuss ivermectin and fenbendazole (17 Jun 2026)
- “Treatment plans” offered in comments
Ask which published study in people is behind it. Usually there is none.
- Anyone who answers your post with a private treatment
Real trials are listed in a public registry. Check the number on ClinicalTrials.gov or the EU trial register.
- Strangers offering investments or “funds” for treatment
Do not reply and do not send money. Report the comment or message.
Before you pay for anything, ask three things
- Can I have a written price, with everything that is included?
- Which published study in people shows it helps my disease?
- What does my doctor say about it?
Questions for your doctor
Ready lists for a new diagnosis, during treatment, before a trial and before you pay. Open the question lists
Not medical advice. We show what is open and what is known; your care team decides what fits you.